BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544445

APL

img img img img
No Data Available

Asston Pharmaceuticals Ltd Share Price Update

As of the latest trading session, Asston Pharmaceuticals Ltd share price is currently at ₹ 96.99, which is down by ₹ -2.00 from its previous closing. Today, the stock has fluctuated between ₹ 93.24 and ₹ 98.52. Over the past year, Asston Pharmaceuticals Ltd has achieved a return of [-] %. In the last month alone, the return has been 19.77 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Asston Pharmaceuticals Ltd fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    82.60

  • P/E Ratio (TTM)

    21.85

  • Beta

    0.42

  • Book Value / share

    45.34

  • Return on equity

    42.28%

  • EPS (TTM)

    4.48

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Asston Pharmaceuticals Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 25.04
Operating Expense 20.59
Net Profit 3.85
Net Profit Margin (%) 15.37
Earnings Per Share (EPS) 6.14
EBITDA 6.01
Effective Tax Rate (%) 23.10
Particulars MAR 2024 (Values in Cr)
Revenue 15.59
Operating Expense 14.02
Net Profit 1.36
Net Profit Margin (%) 8.72
Earnings Per Share (EPS) 17.35
EBITDA 2.80
Effective Tax Rate (%) 25.27
Particulars MAR 2023 (Values in Cr)
Revenue 6.54
Operating Expense 5.77
Net Profit 1.06
Net Profit Margin (%) 16.20
Earnings Per Share (EPS) 15.09
EBITDA 2.17
Effective Tax Rate (%) 25.53
Particulars MAR 2022 (Values in Cr)
Revenue 9.60
Operating Expense 10.39
Net Profit 0.11
Net Profit Margin (%) 1.14
Earnings Per Share (EPS) 1.58
EBITDA 0.60
Effective Tax Rate (%) 31.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.60
ROE % 42.28
ROCE % 36.73
Total Debt to Total Equity 0.77
EBITDA Margin 24.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 91.63
ROE % 53.00
ROCE % 37.65
Total Debt to Total Equity 1.32
EBITDA Margin 25.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.37
ROE % 72.60
ROCE % 36.93
Total Debt to Total Equity 2.93
EBITDA Margin 33.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.28
ROE % 11.83
ROCE % 13.75
Total Debt to Total Equity 3.56
EBITDA Margin 6.25
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 28.12
Total Liabilities 28.12
Total Equity 11.03
Share Outstanding 6271360
Price to Book Ratio 0.00
Return on Assets (%) 13.69
Return on Capital (%) 21.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 20.26
Total Liabilities 20.26
Total Equity 6.39
Share Outstanding 783920
Price to Book Ratio 0.00
Return on Assets (%) 6.71
Return on Capital (%) 10.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 13.69
Total Liabilities 13.69
Total Equity 1.98
Share Outstanding 700000
Price to Book Ratio 0.00
Return on Assets (%) 7.71
Return on Capital (%) 14.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 9.49
Total Liabilities 9.49
Total Equity 0.92
Share Outstanding 700000
Price to Book Ratio 0.00
Return on Assets (%) 1.16
Return on Capital (%) 2.61
Particulars MAR 2025 (Values in Cr)
Net Income 5.01
Cash from Operations 0.00
Cash from Investing 0.73
Cash from Financing -0.51
Net change in Cash 0.19
Free Cash Flow 0.01
Particulars MAR 2024 (Values in Cr)
Net Income 3.25
Cash from Operations -3.51
Cash from Investing 0.00
Cash from Financing 3.85
Net change in Cash -0.11
Free Cash Flow -3.50
Particulars MAR 2023 (Values in Cr)
Net Income 1.41
Cash from Operations -0.30
Cash from Investing -0.91
Cash from Financing 1.21
Net change in Cash -0.01
Free Cash Flow -0.05
Particulars MAR 2022 (Values in Cr)
Net Income 0.15
Cash from Operations -1.15
Cash from Investing 0.00
Cash from Financing 1.29
Net change in Cash 0.10
Free Cash Flow -1.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.76 13.61 1.44 212.73 27.10 / 68.00
BLISS GVS PHARMA LTD 154.90 14.94 1.44 1637.64 105.05 / 190.65
CIPLA LTD 1508.10 22.39 3.70 121819.98 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 269.45 7.08 2.02 793.02 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2520.20 44.79 25.00 42693.71 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.76 22.57 3.86 212.73 27.10 / 68.00
AMRUTAJAN HEALTH LTD 666.00 33.96 5.62 1925.45 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9089.00 98.29 28.43 22722.50 6301.00 / 10653.05
BLISS GVS PHARMA LTD 154.90 20.90 1.48 1637.64 105.05 / 190.65

Asston Pharmaceuticals Ltd shareholding pattern

Holding

43.3%
50.66%
6.03%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Asston Pharmaceuticals Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
96.99 -2.02 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 97.60
  • 26 Days 89.90
  • 10 Days 93.90
  • 50 Days 91.90
  • 12 Days 92.80
  • 100 Days 99.00
  • 20 Days 90.40
  • 200 Days 99.00
102.22 PIVOT

First Support

99.44

First Resistance

107.40

Second Support

94.26

Second Resistance

110.18

Third Support

91.48

Third Resistance

115.36

RSI

59.74

ADX

32.43

MACD

2.94

Williams % R

-20.76

Commodity Channel Index (CCI)

133.77

Date

2025-12-03

Week

23167.00

Same Day

13000.00

Month

15190.00

1 Year

0.42

3 Year

0.44

Over 1 Month

19.77%

down

Over 1 Year

0.00%

down

Over 3 Months

-1.86%

down

Over 3 Years

0.00%

down

Over 6 Months

-20.77%

down

Over 5 Years

0.00%

down

Asston Pharmaceuticals Ltd Corporate Actions

Asston Pharmaceuticals Ltd Share Price

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020. Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.

Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc. Company's operations are supported by experienced founders with expertise in managing supply chains and maintaining product quality.

Currently, Company has its production plant at Ambernath, Maharashtra, for producing generic medicines in the tablet form and nutraceutical medicines in the tablet form, syrup and sachet form. Facility has total production capacity of up to around 8-9 crore tablets per month. Further, it produces an average of 5-6 crore tablets per month, with production capacity varying based on the weight of medicines. Higherweight medicines result in lower production quantities and vice versa. The syrup production capacity for nutraceuticals is approximately 37.5 kiloliters per month, while sachet production capacity ranges from 30 to 40 lakh sachets per month, depending on the powder weight per sachet.

The facility is certified by relevant authorities and undergoes periodic audits by state and central FDA authorities. Company engages contract manufacturers to produce generic medicines and antibiotics in various forms, including tablets, sachets, syrups, and capsules.

The Company has ventured into other African countries to receive registration from the Asian markets like Cambodia and Vietnam in FY 2024.

Company came up with the IPO of 22,41,000 equity shares of Rs 10, by raising Rs 27.56 crore in July, 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Asston Pharmaceuticals Ltd?

Answer Field

Asston Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 96.99 as on Dec 04 2025 03:23 PM.

What is the Market Cap of Asston Pharmaceuticals Ltd Share?

Answer Field

The market cap of Asston Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 82.60 as on Dec 04 2025 03:23 PM.

What is the 52 Week High and Low of Asston Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Asston Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 126.00 and ₹ 75.21.

What is 1 year return for Asston Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on Dec 04 2025 03:23 PM the price-to-earnings (PE) ratio for Asston Pharmaceuticals Ltd share is 21.85.

What is the PB ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on Dec 04 2025 03:23 PM, the price-to-book (PB) ratio for Asston Pharmaceuticals Ltd share is 45.34.

How to Buy Asston Pharmaceuticals Ltd Share?

Answer Field

You can trade in Asston Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Asston Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Asston Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Asston Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59